Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Budesonide MMX 9mg in Healthy Indian Subjects
NCT04080713Phase 1Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Sep 2019
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of EPI-EE in ulcerative colitis (UC), sponsored by Ferring Pharmaceuticals. Primary endpoints: Maximum plasma concentration observed, Pharmacokinetic lag time and 13 more. Started Sep 2019; status: completed.
02
Drugs
EPI-EE
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04080713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04080713.